Skip to content

A Crossover Study to Assess the 2 Glucose Tolerance Tests on Incretin, Beta-cell function and Insulin Sensitivity in Japanese Healthy and Type 2 Diabetes Subjects

A Crossover Study to Assess the 2 Glucose Tolerance Tests on Incretin, Beta-cell function and Insulin Sensitivity in Japanese Healthy and Type 2 Diabetes Subjects - Two Glucose Tolerance Tests on Incretin, beta-cell function and Insulin Sensitivity in Japanese T2DM Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014575
Enrollment
32
Registered
2014-07-16
Start date
2007-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T2DM

Interventions

75g OGTT Mixed meal

Sponsors

Kansai Electric Power Hospital
Lead Sponsor
Department of Diabetes and Clinical Nutrition, Kyoto University Graduate School of Medicine Department of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine Center for Advanced Medicine and Clinical Research, Nagoya University Hospital Department of Biomedical Sciences, University of Copenhagen
Collaborator

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (Healthy volunteers) - free from any disease at screening - fasting plasma glucose less than 110 mg/dL at screening - BMI<27kg/m2 (T2DM volunteers) - Previous diagnosis of T2DM - No anti-diabetic medication - HbA1c (JDS) <7.5 at screening - BMI<27kg/m2

Exclusion criteria

Exclusion criteria: 1) Patients with diabetes requiring insulin therapy (insulin intensive therapy, T1DM, etc) 2) Patients treated with any anti-diabetic drugs 3) Patients with heart disease 4) Patients with renal dysfunction 5) Patients with severe hepatic dysfunction 6) Patients with history of pancreatitis 7) Patients with a history of surgery of gastrointestinal tract 8) Patients with malignant tumor(s) 9) Patients with severe infection, in the perioperative period or with serious injury 10) Excessive alcohol intake or drug abuse 11) Patients found ineligible as a study patient according to the discretion of the investigator or sub-investigator 12)Pregnant or possibly pregnant women

Design outcomes

Primary

MeasureTime frame
To assess effects of two glucose tolerance tests (75g OGTT and mixed meal) on following parameters in Japanese T2DM and healthy volunteers; 1) Changes in plasma glucose levels 2) Changes in serum insulin and C-peptide levels 3) Changes in plasma glucagon levels 4) Changes in plasma GIP (total, intact) levels 5) Changes in plasma GLP-1 (total, intact) levels

Countries

Japan

Contacts

Public ContactDaisuke Yabe

Kansai Electric Power Hospital Center for Diabetes, Endocrinology and Metabolism

ydaisuke-kyoto@umin.ac.jp+81-6-6458-5821

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026